Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications

被引:91
|
作者
Grassi, Guido [1 ,2 ]
Seravalle, Gino [3 ]
Mancia, Giuseppe [1 ,3 ]
机构
[1] Univ Milano Bicocca, Dipartimento Sci Salute, Med Clin, I-20052 Milan, Italy
[2] Sesto San Giovanni, IRCCS Multimed, Milan, Italy
[3] Ist Auxol Italiano, Milan, Italy
关键词
Congestive heart failure; drug treatment; hypertension; myocardial infarction; prognosis; sympathetic nervous system; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; HEART-FAILURE; PLASMA NOREPINEPHRINE; BAROREFLEX FUNCTION; RENAL DENERVATION; SENSITIVITY; MOXONIDINE; MORTALITY; RESPONSES;
D O I
10.1111/eci.12553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The sympathetic nervous exerts a key role in cardiovascular homeostasis control by regulating cardiac output, systemic vascular resistance, heart rate and blood pressure. Materials and methods Data collected during the past 30 years have unequivocally shown that in a considerable number of cardiovascular as well as noncardiovascular disease there is a marked activation of the sympathetic nervous system which exerts in the long-term period unfavourable haemodynamic, metabolic, cardiovascular and renal effects. Results This paper will review the current knowledge on the alterations in sympathetic function described in cardiovascular disease, with particular focus on hypertension, heart failure and myocardial infarction. Conclusions The consequences of the phoenomenon will be discussed together with its therapeutic implications. This will be done by examining the impact of nonpharmacological as well as pharmacological interventions on sympathetic cardiovascular drive. The effects of new invasive approaches, such as carotid baroreceptor stimulation as well as renal nerves ablation, will be also briefly discussed.
引用
收藏
页码:1367 / 1375
页数:9
相关论文
共 50 条
  • [31] Oxidative pathways in cardiovascular disease - Roles, mechanisms, and therapeutic implications
    Wattanapitayakul, SK
    Bauer, JA
    PHARMACOLOGY & THERAPEUTICS, 2001, 89 (02) : 187 - 206
  • [32] Therapeutic implications of the gender-specific aspects of cardiovascular disease
    Vera Regitz-Zagrosek
    Nature Reviews Drug Discovery, 2006, 5 : 425 - 439
  • [33] Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications
    Han, Chaoshan
    Yang, Junjie
    Sun, Jiacheng
    Qin, Gangjian
    PHARMACOLOGY & THERAPEUTICS, 2022, 233
  • [34] Diagnostic and Therapeutic Implications of Erectile Dysfunction in Patients with Cardiovascular Disease
    Gandaglia, Giorgio
    Briganti, Alberto
    Montorsi, Piero
    Mottrie, Alexandre
    Salonia, Andrea
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2016, 70 (02) : 219 - 222
  • [35] Clinical evidence of resveratrol bioactivity in cardiovascular disease
    Bhullar, Khushwant S.
    Udenigwe, Chibuike C.
    CURRENT OPINION IN FOOD SCIENCE, 2016, 8 : 68 - 73
  • [36] Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications
    Chen, Jun
    Zhong, Jinjie
    Wang, Lin-lin
    Chen, Ying-ying
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [37] Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications
    Bover, Jordi
    Urena-Torres, Pablo
    Luis Gorriz, Jose
    Jesus Lloret, Maria
    da Silva, Iara
    Ruiz-Garcia, Cesar
    Chang, Pamela
    Rodriguez, Mariano
    Ballarin, Jose
    NEFROLOGIA, 2016, 36 (06): : 597 - 608
  • [38] Therapeutic implications of the gender-specific aspects of cardiovascular disease
    Regitz-Zagrosek, V
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (05) : 425 - 438
  • [39] The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications
    Silveira, Erika Aparecida
    da Silva Filho, Romulo Roosevelt
    Spexoto, Maria Claudia Bernardes
    Haghighatdoost, Fahimeh
    Sarrafzadegan, Nizal
    de Oliveira, Cesar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [40] Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications
    Cazzola, Mario
    Hanania, Nicola A.
    Rogliani, Paola
    Matera, Maria Gabriella
    KARDIOLOGIA POLSKA, 2023, 81 (03) : 232 - 241